Hinge Health, led by co-founders Daniel Perez and Gabriel Mecklenburg, rings the opening bell at the New York Stock Exchange on May 22, 2025 (Photo credit: NYSE)

May 22, 2025 01:26 PM EDTUpdated 04:17 PM

Deals

Health Tech

Updated: Hinge Health jumped 18% on its first day as the digital health IPO market reawakens

Ngai Yeung

Health Tech Reporter

Hinge Health ended its first day of trading with shares $HNGE up 18%, setting the tone for digital health after a drought of IPOs in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Updated: Hinge Health jumped 18% on its first day as the digital health IPO market reawakens

Ngai Yeung

Health Tech Reporter

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Meet the ‘first sale’ rule: A customs loophole pharma companies could use to ease tariff impact

The ‘MAHA report’: Four key takeaways on vaccines, medicine and the pharma industry

FDA adcomm votes unanimously against Pfizer's prostate cancer drug combo

Post-Hoc: AI bio needs to heed the overhyped history of CRISPR

Sanofi makes $470M move for Vigil's Alzheimer's drug, while another asset returns to Amgen

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?

Up­dat­ed: Hinge Health jumped 18% on its first day as the dig­i­tal health IPO mar­ket reawak­ens

Health Tech Reporter

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Updated: Hinge Health jumped 18% on its first day as the digital health IPO market reawakens